Search - tctmd.com

Displaying 21 - 31 of 31

Sort: Relevancy | Date

Presentation NY Valves 2024

Transcatheter Amplatzer Vascular Plug to Treat Peri-Device Leak After Left Atrial Appendage (LAAO) Closure

Presenter: Saurabh Gupta

June 05, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Conference News ESOC 2024

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

Todd Neale

May 17, 2024

News Daily News

Potential Contributors to ESUS Explored in New Consensus Statement

Todd Neale

May 14, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Conference News STS 2024

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

Yael L. Maxwell

February 09, 2024

Presentation Complex Coronary Cases 2023

Femoral Approach and Closure Devices to Reduce Vascular Complications

Presenter: Raman Sharma

June 16, 2023

Presentation Complex Coronary Cases 2023

My Worst Vascular Access Case

Presenter: Raj Tayal

June 15, 2023

Advertisement

Transcatheter Amplatzer Vascular Plug to Treat Peri-Device Leak After Left Atrial Appendage (LAAO) Closure

June 2024 Dispatch for the CV Team

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

Potential Contributors to ESUS Explored in New Consensus Statement

May 2024 Dispatch for the CV Team

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

April 2024 Dispatch for the CV Team

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

Femoral Approach and Closure Devices to Reduce Vascular Complications

My Worst Vascular Access Case

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content